Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer

B. van Veggel; A. van der Wekken; S. Hashemi; R. Cornelissen; K. Monkhorst; D. Heideman; T. Radonic; E. F. Smit; E. Schuuring; J. De Langen

doi:https://doi.org/10.1093/annonc/mdy292.072

Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer

B. van Veggel, A. van der Wekken, S. Hashemi, R. Cornelissen, K. Monkhorst, D. Heideman, T. Radonic, E. F. Smit, E. Schuuring, J. De Langen

Research output: Contribution to journal › Article › Academic › peer-review

36 Citations (Scopus)

Original language	English
Pages (from-to)	viii524-viii525
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy292.072
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy292.072

Cite this

van Veggel, B., van der Wekken, A., Hashemi, S., Cornelissen, R., Monkhorst, K., Heideman, D., Radonic, T., Smit, E. F., Schuuring, E., & De Langen, J. (2018). Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii524-viii525. https://doi.org/10.1093/annonc/mdy292.072

@article{f9cae652f8f2486087f66f2417675d6b,

title = "Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer",

author = "{van Veggel}, B. and {van der Wekken}, A. and S. Hashemi and R. Cornelissen and K. Monkhorst and D. Heideman and T. Radonic and Smit, {E. F.} and E. Schuuring and {De Langen}, J.",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy292.072",

language = "English",

volume = "29",

pages = "viii524--viii525",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

van Veggel, B, van der Wekken, A, Hashemi, S, Cornelissen, R, Monkhorst, K, Heideman, D , Radonic, T, Smit, EF, Schuuring, E & De Langen, J 2018, 'Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii524-viii525. https://doi.org/10.1093/annonc/mdy292.072

TY - JOUR

T1 - Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer

AU - van Veggel, B.

AU - van der Wekken, A.

AU - Hashemi, S.

AU - Cornelissen, R.

AU - Monkhorst, K.

AU - Heideman, D.

AU - Radonic, T.

AU - Smit, E. F.

AU - Schuuring, E.

AU - De Langen, J.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081527789&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy292.072

DO - https://doi.org/10.1093/annonc/mdy292.072

M3 - Article

C2 - 32137361

SN - 0923-7534

VL - 29

SP - viii524-viii525

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer

Access to Document

Other files and links

Cite this